Material Properties and Cell Compatibility of Photo-Crosslinked Sericin Urethane Methacryloyl Hydrogel.

cell encapsulation mesenchymal stem cells natural hydrogel sericin urethane methacryloyl silk sericin

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
29 Aug 2022
Historique:
received: 19 07 2022
revised: 24 08 2022
accepted: 24 08 2022
entrez: 22 9 2022
pubmed: 23 9 2022
medline: 23 9 2022
Statut: epublish

Résumé

There is a need to develop novel cytocompatible hydrogels for cell encapsulation and delivery in regenerative medicine. The objective of this work was to synthesize isocyanato ethyl methacryloyl-functionalized sericin and determine its material properties as a natural hydrogel for the encapsulation and delivery of human mesenchymal stem cells (MSCs) in regenerative medicine. Sericin extracted from silk cocoons was reacted with 2-isocyanatoethyl methacrylate (IEM) or methacrylic anhydride (MA) to produce sericin urethane methacryloyl (SerAte-UM) or sericin methacryloyl (SerAte-M, control) biopolymers, respectively. The hydrogels produced by photo-crosslinking of the biopolymers in an aqueous solution were characterized with respect to gelation kinetics, microstructure, compressive modulus, water content, degradation, permeability, and viability of encapsulated cells. The secondary structure of citric acid-extracted sericin was not affected by functionalization with IEM or MA. SerAte-UM hydrogel was slightly more hydrophilic than SerAte-M. The gelation time of SerAte-UM hydrogel decreased with an increasing degree of modification. The photo-polymerized SerAte-UM hydrogel had a highly porous, fibrous, honeycomb microstructure with an average pore size in the 40−50 µm range. The compressive modulus, swelling ratio, and permeability of SerAte-UM hydrogel depended on the degree of modification of sericin, and the mass loss after 21 days of incubation in aqueous solution was <25%. Both SerAte-UM and SerAte-M hydrogels supported viability and growth in encapsulated MSCs. The SerAte-UM hydrogel, with its higher hydrophilicity compared to SerAte-M, is promising as a matrix for encapsulation and delivery of stem cells in tissue engineering.

Identifiants

pubmed: 36135255
pii: gels8090543
doi: 10.3390/gels8090543
pmc: PMC9498915
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAMS NIH HHS
ID : 063745
Pays : United States

Références

Macromol Biosci. 2012 Mar;12(3):322-32
pubmed: 22493796
Eur Polym J. 2015 Nov 1;72:566-576
pubmed: 26688592
Polymers (Basel). 2021 Jun 25;13(13):
pubmed: 34202237
Gels. 2021 Nov 16;7(4):
pubmed: 34842678
Acta Biomater. 2012 Jul;8(7):2620-7
pubmed: 22484695
Adv Drug Deliv Rev. 2019 Sep - Oct;149-150:95-106
pubmed: 31421149
Biosci Biotechnol Biochem. 2004 Apr;68(4):774-80
pubmed: 15118302
Mater Sci Eng C Mater Biol Appl. 2015 Sep;54:76-83
pubmed: 26046270
Acta Biomater. 2020 Jan 1;101:1-13
pubmed: 31476385
Biomed Res Int. 2016;2016:8175701
pubmed: 27965981
Biomacromolecules. 2005 Nov-Dec;6(6):3380-7
pubmed: 16283769
Biomaterials. 2013 Sep;34(28):6785-96
pubmed: 23773819
Adv Healthc Mater. 2022 Feb;11(3):e2101357
pubmed: 34879177
Biomacromolecules. 2012 Jul 9;13(7):2073-86
pubmed: 22642902
Molecules. 2020 Dec 11;25(24):
pubmed: 33322369
Int J Pharm. 2021 Jun 15;603:120673
pubmed: 33964338
Gels. 2019 May 29;5(2):
pubmed: 31146448
PLoS One. 2013 Sep 13;8(9):e74779
pubmed: 24058626
Biomater Sci. 2018 Nov 1;6(11):2859-2870
pubmed: 30259043
Bioact Mater. 2021 Apr 15;6(11):3904-3923
pubmed: 33997485
Ann Transl Med. 2020 Dec;8(23):1598
pubmed: 33437797
Adv Healthc Mater. 2019 Sep;8(17):e1900698
pubmed: 31359632
Biomacromolecules. 2020 Feb 10;21(2):294-304
pubmed: 31771325
Acta Biomater. 2009 Jul;5(6):1872-83
pubmed: 19328754
Tissue Eng Part A. 2021 Jun;27(11-12):679-702
pubmed: 33499750
Biomaterials. 2015 Jul;58:26-34
pubmed: 25941779
Tissue Eng Part B Rev. 2017 Apr;23(2):183-198
pubmed: 27824295
J Biomed Mater Res A. 2009 Jul;90(1):142-53
pubmed: 18491397
Acta Biomater. 2016 Sep 1;41:210-23
pubmed: 27262742
Adv Healthc Mater. 2015 Oct 28;4(15):2195-205
pubmed: 26332703
Biomaterials. 2018 May;163:89-104
pubmed: 29455069
Biosci Biotechnol Biochem. 2005 Feb;69(2):403-5
pubmed: 15725668
Biomacromolecules. 2017 Feb 13;18(2):398-412
pubmed: 28000441
Nanomaterials (Basel). 2018 Apr 13;8(4):
pubmed: 29652825
Sci Rep. 2014 Nov 20;4:7064
pubmed: 25412301
Acta Biomater. 2018 Jul 1;74:385-396
pubmed: 29783089
Biomacromolecules. 2004 Jul-Aug;5(4):1392-8
pubmed: 15244456
Acta Biomater. 2008 Jan;4(1):17-25
pubmed: 18029236
Biomaterials. 2006 Jun;27(18):3379-86
pubmed: 16510179
Cell Transplant. 2012;21(2-3):617-22
pubmed: 22793071
Biotechnol Appl Biochem. 2010 Feb 18;55(2):91-8
pubmed: 20055756
Mar Drugs. 2021 Dec 15;19(12):
pubmed: 34940707

Auteurs

Safaa Kader (S)

Biomaterials and Tissue Engineering Laboratory, Department of Chemical Engineering, Swearingen Engineering Center, Rm 2C11, University of South Carolina, Columbia, SC 29208, USA.
Department of Pathology and Forensic Medicine, College of Medicine, Al-Nahrain University, Baghdad 10006, Iraq.

Esmaiel Jabbari (E)

Biomaterials and Tissue Engineering Laboratory, Department of Chemical Engineering, Swearingen Engineering Center, Rm 2C11, University of South Carolina, Columbia, SC 29208, USA.

Classifications MeSH